p21 Expression is increased by irradiation in esophageal squamous cell carcinoma

Journal of Surgical Research

Volumn 76, Issue 2, 1998, Pages 137-142

  Rigberg, David A ^a   Kim, Frances S ^a   Blinman, Thane A ^a   Cole, Michael A ^a   Lane, John S ^a   So, Jennifer ^a   McFadden, David W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Esophageal cancer; P21; P53; Squamous cell

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P21;

ANIMAL CELL; CANCER RADIOTHERAPY; CELL SURVIVAL; CONFERENCE PAPER; DNA DAMAGE; DNA REPAIR; ESOPHAGUS CARCINOMA; GENE MUTATION; IRRADIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; RADIATION INJURY; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0032079210     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1998.5308     Document Type: Conference Paper

References (26)

1. Swisher S. G., Hunt K. K., Holmes E. C., Zinner M. J., McFadden D. W. Changes in the surgical management of esophageal cancer from 1970 to 993. Am. J. Surg. 169:1995;609.
2. Berrino F., Sant M., Verdecchia A., Capacaccia R., Hakulinen T., Esteve J. Survival of Cancer Patients in Europe - The Eurocare Study. 1995;IARC, Lyon.
3. Blot W. J., Devesa S. S., Kneller R. W., Fraumeni J. F. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 265:1991;1287.
4. Altorki N. K., Skinner D. B. Adenocarcinoma in Barrett's esophagus. Semin. Surg. Oncol. 6:1990;274.
5. Kelsen D., Atiq O. T. Therapy of upper gastrointestinal tract cancers. Curr. Prob. Cancer. 15:1991;235.
6. Bhansali M. S., Patil P. K., Badwe R. A., Havaldar R., Desai P. B. Historical control bias; adjuvant chemotherapy in esophageal cancer. Dis. Esoph. 10:1997;51.
7. Wadler S., Hayner H., Beitler J. J., Hu X., Fell S., Camacho M., Levine B., Wiernik P. H. Phase II clinical trial with 5-FU, recombinant interferon-alpha-2b and cisplatin for patients with metastatic or regionally advanced carcinoma of the esophagus. Cancer. 78:1996;30.
8. Tanaka H., Shibagak I., Shimada Y., Wagata T., Imamura M., Ishizaki K. Characterization of p53 gene mutations in esophageal squamous cell carcinoma cell lines: increased frequency and different spectrum of mutations from primary tumors. Int. J. Cancer. 65:1996;372.
9. El-Deiry W. S., Tokino T., Velculescu V. E., Levy D. B., Parsons R., Trent J. M., Lin D., Mercer W. E., Kinzler K. W., Vogelstein B. WAF-1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817.
10. Macleod K. F., Sherry N., Hannon G., Beach D., Tokino T., Kinzler K., Vogelstein B., Jacks T. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev. 9:1995;935.
11. El-Deiry W. S., Harper J. W., O'Conner P. M., Velculescu V. E., Canman C. E., Jackman J., Pietenpol J. A., Burrell M., Hill D. E., Wang Y., Wiman K. G., Mercer W. E., Kastan M. B., Kohn K. W., Elledge S. J., Kinzler K. W., Vogelstein B. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54:1994;1169.
12. Wang J., Walsh K. Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science. 273:1996;359.
13. Barnas C., Martel-Planche G., Furukawa Y., Hollstein M., Montesano R., Hainaut P. Inactivation of the p53 protein in cell lines derived from human esophageal cancers. Int. J. Cancer. 71:1997;79.
14. Nabeya Y., Loganzo F., Maslak P., Lai L., De Oliveira A. R., Schwartz G. K., Blundell M. L., Altorki N. K., Kelsen D. P., Albino A. P. The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents. Int. J. Cancer. 64:1995;37.
15. Fujiwara T., Grimm E. A., Mukhopadhyay T., Zhang W. W., Owen-Schaub L. B., Roth J. A. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res. 54:1994;2287.
16. Lowe S. W., Ruley H. E., Jacks T., Housman D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 74:1993;957.
17. Brachman D. G., Beckett M., Graves D., Haraf D., Vokes E., Weichselbaum R. R. p53 mutation does not correlate with radiosensitivity in 24 head-and-neck cancer cell lines. Cancer Res. 53:1993;3667.
18. Rigberg D. A., Kim F. S., Lee S., Cole M. A., McFadden D. W. Differential expression of p53 and p21 in chemotherapeutic treatment of esophageal squamous cell carcinoma in vitro. Surg Forum. 48:1997;809.
19. Sheikh M. S., Rochefort H., Garcia M. Overexpression of p21 WAF1/CIP1 induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines. Oncogene. 18:1995;1899.
20. Prabhu N. S., Blagosklonny M. V., Zeng Y. X., Wu G. S., Waldman T., El Deiry W. S. Suppression of cancer cell growth by adenovirus expressing p21 (WAF1/cip1) deficient in pcna interaction. Clin. Cancer Res. 2:1996;1221.
21. El Deiry W. S., Harper J. W., O'Connor P. M., Velculescu V. E., Canman C. E., Jackman J., Pietenpol J. A., Burrell M., Hill D. E., Wang Y., Wilman K. G., Mercer W. E., Kastan M. B., Kohn K. W., Elledge S. J., Kinzler K. W., Vogelstein B. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54:1994;1169.
22. Steinman R. A., Hofffman B., Iro A., Guillouf C., Liebermann D. A., El-Houseini M. E. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene. 9:1994;3389.
23. Canman C. E., Gilmer T. M., Coutts S. B., Kastan M. B. Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev. 9:1995;600.
24. Tanaka H., Shibagaki I., Shimada Y., Wagata T., Imamura M., Ishizaki K. Characterization of p53 gene mutations in esophageal squamous cell carcinoma cell lines: increased frequency and different spectrum of mutations from primary tumors. Int. J. Cancer. 65:1996;372.
25. Smith M. L., Kontny H. U., Bortnick R., Fornace A. J. Jr. The p53-regulated cyclin G gene promotes cell growth: p53 downstream effectors cyclin G and Gadd45 exert different effects on cisplatin chemosensitivity. Exp. Cell Res. 230:1997;61.
26. Meyn R. E. Apoptosis and response to radiation: implications for radiation therapy. Oncology. 11:1997;349.